BII
ABBV icon

Bainco International Investors’s AbbVie ABBV Stock Holding History

Bainco International Investors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$11.6M Buy
108,447
+3,865
+4% +$371K 1.33% 21
2020
Q3 		$9.16M Buy
104,582
+1,572
+2% +$148K 1.16% 27
2020
Q2 		$10.1M Buy
103,010
+41,219
+67% +$3.63M 1.43% 17
2020
Q1 		$4.71M Sell
61,791
-1,049
-2% -$89.4K 0.82% 48
2019
Q4 		$5.56M Sell
62,840
-823
-1% -$68.3K 0.79% 50
2019
Q3 		$4.82M Sell
63,663
-1,481
-2% -$102K 0.75% 52
2019
Q2 		$4.74M Sell
65,144
-4,385
-6% -$345K 0.75% 51
2019
Q1 		$5.6M Sell
69,529
-3,125
-4% -$256K 0.91% 47
2018
Q4 		$6.7M Sell
72,654
-45,350
-38% -$3.99M 1.16% 36
2018
Q3 		$11.2M Buy
118,004
+1,391
+1% +$132K 1.53% 24
2018
Q2 		$10.8M Sell
116,613
-1,636
-1% -$160K 1.56% 18
2018
Q1 		$11.2M Sell
118,249
-1,914
-2% -$210K 1.67% 18
2017
Q4 		$13.4M Sell
120,163
-26,947
-18% -$2.54M 1.96% 14
2017
Q3 		$13.1M Buy
147,110
+6,460
+5% +$492K 1.57% 15
2017
Q2 		$10.2M Sell
140,650
-780
-0.6% -$52.4K 1.53% 19
2017
Q1 		$9.22M Sell
141,430
-21,175
-13% -$1.33M 1.3% 25
2016
Q4 		$10.2M Buy
162,605
+9,411
+6% +$574K 1.73% 23
2016
Q3 		$9.66M Buy
153,194
+730
+0.5% +$47.3K 1.76% 20
2016
Q2 		$9.44M Buy
152,464
+8,514
+6% +$519K 2.03% 16
2016
Q1 		$8.22M Buy
143,950
+10,350
+8% +$577K 1.99% 19
2015
Q4 		$7.91M Buy
133,600
+470
+0.4% +$27.1K 1.78% 16
2015
Q3 		$26.3M Buy
133,130
+3,475
+3% +$226K 6.42% 2
2015
Q2 		$8.71M Buy
129,655
+6,500
+5% +$424K 1.95% 11
2015
Q1 		$7.21M Buy
123,155
+6,630
+6% +$401K 1.62% 17
2014
Q4 		$7.63M Buy
116,525
+52,585
+82% +$3.32M 1.81% 12
2014
Q3 		$3.69M Buy
63,940
+1,200
+2% +$66.6K 0.92% 42
2014
Q2 		$3.54M Sell
62,740
-2,800
-4% -$147K 0.88% 44
2014
Q1 		$3.37M Sell
65,540
-6,225
-9% -$315K 0.86% 48
2013
Q4 		$3.79M Buy
71,765
+2,400
+3% +$118K 0.92% 45
2013
Q3 		$3.1M Buy
69,365
+3,430
+5% +$152K 0.77% 48
2013
Q2 		$2.73M Buy
+65,935
New +$2.88M 0.76% 51

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bainco International Investors's ABBV Position: Q4 2020 in Review

Bainco International Investors increased its AbbVie (ABBV) stake by 3.7% in Q4 2020, buying an estimated $371K and bringing the position to 108,447 shares worth $11.6M. The position accounts for 1.33% of the portfolio, ranked #21.

Bainco International Investors first reported a position in ABBV in Q2 2013 and has held it in 31 quarters since. The position peaked at $26.3M in Q3 2015. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Bainco International Investors held 108,447 shares of AbbVie worth $11.6M as of Q4 2020.
  • Bainco International Investors bought 3,865 AbbVie shares in Q4 2020, an estimated $371K.
  • AbbVie made up 1.33% of Bainco International Investors's portfolio in Q4 2020, its #21 holding.
  • Bainco International Investors first reported a position in AbbVie in Q2 2013 and has held it in 31 quarters since.
  • Bainco International Investors's AbbVie position peaked at $26.3M in Q3 2015.
  • 2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.